Affected patients should not stop taking their medication suddenly but should contact their doctor or pharmacy immediately
Updated opioid safety labeling is based on new data from two large postmarketing observational studies
77 percent of the cases of pediatric exposure reported to U.S. poison control centers were for unintentional exposure
Regulatory actions by the FDA were corroborated by at least one relevant published research study for 17 of 57 resolved safety signals